ACEMg for Sudden Hearing Loss or Sudden Deafness
Sudden Sensorineural Hearing Loss (SSNHL) is considered a medical emergency.
If you experience a sudden loss of hearing, please contact hello@soundbites.com immediately with your U.S. mailing address to receive an expedited shipment. Then arrange for an otoacoustic emissions (OAE) examination to assess your inner ear auditory function and then monitor potential recovery.
If you experience a sudden loss of hearing, please contact hello@soundbites.com immediately with your U.S. mailing address to receive an expedited shipment. Then arrange for an otoacoustic emissions (OAE) examination to assess your inner ear auditory function and then monitor potential recovery.
Often, SSNHL has no identifiable cause. However, pathological processes underlying the condition are believed to include sudden reductions in cochlear blood flow, inflammation, and increased oxidative stress. These processes can lead to the rapid death of cochlear hair cells, which are essential for translating sound waves into neural signals.
The therapeutic potential of ACEMg in SSNHL is supported by its ability to:
- Mitigate Oxidative Stress: The biomedicine formula ACEMg is patented to act synergistically to reduce cochlear oxidative damage. This is particularly relevant in cases where SSNHL is suspected to result from sudden increases in oxidative stress, such as in viral or vascular incidents.
- Support Cochlear Blood Flow: Magnesium’s vasodilatory properties improve blood flow within the cochlea, countering ischemic events that could precipitate SSNHL. This improved circulation aids in the delivery of essential nutrients and the removal of metabolic byproducts.